DANDRITE

The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership, and performs basic and translational research in brain and the nervous system.

FIMM

The Institute for Molecular Medicine Finland (FIMM) is the Finnish node of the Nordic EMBL Partnership. FIMM’s research interests are human genomics and personalized medicine, with a focus on translational research.

MIMS

The Laboratory for Molecular Infection Medicine Sweden (MIMS) is the Swedish node of the Nordic EMBL Partnership. MIMS aims to strengthen Swedish research and enhance the dynamics in the field of molecular medicine.

NCMM

Centre for Molecular Medicine Norway (NCMM) is the Norwegian node of the Nordic EMBL Partnership. NCMM conducts molecular medicine & biotech research and works translate these findings into clinical practice.

Latest News

2020.05.22 | Research news

Researcher profile: Camila Esguerra

Dr Camila Esguerra joined NCMM in 2014. Her research involves using zebrafish as a model to study brain function in health and disease. In this profile article, Camila discusses her research career so far, the benefits of using zebrafish in translational research, and her visions and plans for the future.

2020.05.07 | Research news

EMBL-EBI launches COVID-19 Data Platform

EMBL's European Bioinformatics Institute (EMBL-EBI) at Hinxton, UK, has created the COVID-19 Data Portal to help coordinate viral genome sequence data across Europe

2020.04.21 | News from the management

Nordic EMBL Partnership awarded NordForsk funding

Grant awarded as part of Nordic Research Infrastructure Hubs call

LRRK2, DANi-011A, iPSC line generated by Sendai virus reprogramming. A) iPSCs stain positive for Alkaline phosphatase. B) Expression of pluripotent markers OCT4 and NANOG. C) DNA sequencing confirms the LRRK2 G2019S variant. D) Reprogrammed iPSCs no longer contain Sendai viruses. Credit: Denham group

2020.04.16 | Publication, Knowledge exchange

New pluripotent stem cell line generated from a Parkinson’s disease patient is aimed at studying PD mechanisms and as a drug-screening platform

Denham group at DANDRITE and colleague researchers have developed a new stem cell line (DANi-011A) from a Parkinson’s disease (PD) patient carrying a LRRK2 p.G2019S mutation that is identified in inherited and sporadic cases of PD. The established cell line enables in vitro modelling of PD and the development of potential treatment strategies for…

Showing results 1 to 4 of 49

1 2 3 4 5 6 7 8 9 10 Next

Upcoming Partnership Events

Tue 02 Jun: 08:00-17:00 | Umeå University, Umeå, Sweden
Cryo-EM sample preparation and data collection
The purpose of the course is to prepare and train our users in sample preparation methods, introduce users to the image data acquisition workflow, expand knowledge about cryo-EM methods and learn how to use cryo-EM.(Registration TBA)
Thu 18 Jun: 09:00-13:15 | Aarhus University, Aarhus, Denmark
EMDS 2020; Macrophages and Dendritic Cells in Infection and Inflammation: Molecular Mechanisms and Roles in Pathology
The 34th Annual Conference is for scientists interested in basic and clinical aspects of monocytes, macrophages, dendritic cells and other myleoid cells in man and experimental animal models.
Fri 02 Oct: 13:00-14:00 | Aarhus, Denmark
Joint DANDRITE-Biomedicine/ Neuroscience Lecture
Joint DANDRITE-Biomedicine/Neuroscience Lecture with Nobel laureate in Psychology or medicine 2014 Dr Edvard Ingjald Moser. Dr Edvard Ingjald Moser will give a talk on "Space and time: Internal dynamics of the brain's entorhinal cortex"

Follow us!

Follow @NordicEMBL

Nordic EMBL Partnership for Molecular Medicine

The Nordic EMBL Partnership for Molecular Medicine combines the complementary research expertise of the Nordic countries with a common aim to address some of the biggest challenges in biomedicine today.